Biomerica (NASDAQ:BMRA) Share Price Passes Above 200 Day Moving Average – Here’s What Happened

Shares of Biomerica, Inc. (NASDAQ:BMRA) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.47 and traded as high as $0.55. Biomerica shares last traded at $0.54, with a volume of 76,444 shares traded.

Biomerica Price Performance

The stock has a market capitalization of $9.81 million, a PE ratio of -1.57 and a beta of 0.37. The company has a 50 day moving average price of $0.66 and a 200-day moving average price of $0.47.

Biomerica (NASDAQ:BMRA) last issued its quarterly earnings data on Tuesday, January 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

Institutional Trading of Biomerica

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC lifted its position in Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 658,767 shares of the company’s stock after acquiring an additional 131,306 shares during the period. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 as of its most recent SEC filing. Institutional investors and hedge funds own 22.28% of the company’s stock.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.